July 03, 2023
A New Jersey federal judge has sided with drugmaker Orexo in a patent suit lodged against competitor Sun Pharmaceuticals over generic versions of opioid addiction treatment Zubsolv, upholding the asserted biotechnology and deeming it infringed by the challenged generics.